首页> 美国卫生研究院文献>other >Sudden Death After Transcatheter Aortic Valve Implantation. Are Bradyarrhythmias Always The Cause?
【2h】

Sudden Death After Transcatheter Aortic Valve Implantation. Are Bradyarrhythmias Always The Cause?

机译:经导管主动脉瓣植入后猝死。缓慢性心律失常总是原因吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transcatheter Aortic-Valve Implantation (TAVI) is considered to be highly effective in the treatment of high-risk patients with severe aortic stenosis. After TAVI, the rate of pacemaker implantation is 6.5%-40%. Some reports of sudden death after TAVI are mostly attributed to bradyarrhythmias. We report the case of three patients who experienced sudden cardiac death or aborted sudden cardiac death after TAVI. All patients were affected from ischemic heart disease with an ejection fraction of approximately 40% and underwent pacemaker implantation (PM) after the procedure due to 1rst degree atrioventricular block (AV) and left bundle branch block (LBBB). One of the patients died suddenly 30 days after the procedure. The PM interrogation revealed many episodes of non sustain ventricular tachycardias (NSVT) and one episode of ventricular fibrillation (VF) that led to death. The other two patients had syncope and during PM interrogation episodes of ventricular tachycardia >12 sec were recorded. Patients affected by ischemic heart disease undergoing TAVI, especially with borderline coronary lesions should receive particular attention in order to avoid potentially lethal ventricular arrhythmias. In addition, the physiopathologic mechanism of sudden arrhythmic death in these patients needs to be clarified.
机译:经导管主动脉瓣植入术(TAVI)被认为在治疗具有严重主动脉瓣狭窄的高危患者中非常有效。 TAVI后,起搏器植入率为6.5%-40%。 TAVI后突然死亡的一些报道主要归因于心律失常。我们报告了三例患者在TAVI后经历了心源性猝死或中止心源性猝死的病例。所有患者均患有缺血性心脏病,其射血分数约为40%,并且由于第1级房室传导阻滞(AV)和左束支传导阻滞(LBBB)而在手术后接受了起搏器植入(PM)。手术后30天,一名患者突然死亡。 PM的询问显示许多发作性非持续性室性心动过速(NSVT)和发作性室性纤颤(VF)导致死亡。另外两名患者出现晕厥,在PM询问期间记录了室性心动过速> 12秒。患有缺血性心脏病的患者接受TAVI治疗,尤其是伴有边缘性冠状动脉病变的患者,应特别注意,以避免可能致命的室性心律失常。此外,这些患者突然心律失常性死亡的生理病理机制需要弄清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号